| Karl D Metzger, MD | |
|
201 Nw R D Mize Rd, Blue Springs, MO 64014-2513 | |
| (816) 943-5713 | |
| Not Available |
| Full Name | Karl D Metzger |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 201 Nw R D Mize Rd, Blue Springs, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376862763 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | ME110967 (Florida) | Secondary |
| 208M00000X | Hospitalist | 2023041699 (Missouri) | Primary |
| 208M00000X | Hospitalist | C152342 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Marys Medical Center | Blue springs, MO | Hospital |
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Sutter Roseville Medical Center | Roseville, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
| Prime Healthcare Kansas City - Physician Services Llc | 7315267325 | 79 |
News Archive
The University of Pittsburgh Medical Center (UPMC) today announced the development of personal health record (PHR) technology that may soon give patients the ability to add critical health information to the electronic health records maintained by hospitals and physicians. UPMC completed the proof-of-concept project in collaboration with Google Health, Carnegie Mellon University (CMU) and technology partner dbMotion.
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, in Canada at St. Joseph's Healthcare - Hamilton, Ontario.
New research presented at ACR Convergence, the American College Rheumatology's annual meeting, showed that patients with rheumatic diseases whose infliximab treatment was individually assessed and adjusted with a new strategy called therapeutic drug monitoring did not achieve remission at higher rates compared to those who received standard care.
The best protection against new SARS-CoV-2 infections or reinfections may be obtained by a combination of vaccine-elicited and infection-induced antibodies.
Cell reprogramming converts specialised cells such as nerve cells or skin cells towards an embryonic stem cell state. This reversal in the evolutionary development of cells also requires a reversal in the biology of telomeres, the structures that protect the ends of chromosomes; whilst under normal conditions telomeres shorten over time, during cell reprogramming they follow the opposite strategy and increase in length.
› Verified 9 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
The University of Pittsburgh Medical Center (UPMC) today announced the development of personal health record (PHR) technology that may soon give patients the ability to add critical health information to the electronic health records maintained by hospitals and physicians. UPMC completed the proof-of-concept project in collaboration with Google Health, Carnegie Mellon University (CMU) and technology partner dbMotion.
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, in Canada at St. Joseph's Healthcare - Hamilton, Ontario.
New research presented at ACR Convergence, the American College Rheumatology's annual meeting, showed that patients with rheumatic diseases whose infliximab treatment was individually assessed and adjusted with a new strategy called therapeutic drug monitoring did not achieve remission at higher rates compared to those who received standard care.
The best protection against new SARS-CoV-2 infections or reinfections may be obtained by a combination of vaccine-elicited and infection-induced antibodies.
Cell reprogramming converts specialised cells such as nerve cells or skin cells towards an embryonic stem cell state. This reversal in the evolutionary development of cells also requires a reversal in the biology of telomeres, the structures that protect the ends of chromosomes; whilst under normal conditions telomeres shorten over time, during cell reprogramming they follow the opposite strategy and increase in length.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karl D Metzger, MD 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: (913) 588-5000 | Karl D Metzger, MD 201 Nw R D Mize Rd, Blue Springs, MO 64014-2513 Ph: (816) 943-5713 |
News Archive
The University of Pittsburgh Medical Center (UPMC) today announced the development of personal health record (PHR) technology that may soon give patients the ability to add critical health information to the electronic health records maintained by hospitals and physicians. UPMC completed the proof-of-concept project in collaboration with Google Health, Carnegie Mellon University (CMU) and technology partner dbMotion.
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, in Canada at St. Joseph's Healthcare - Hamilton, Ontario.
New research presented at ACR Convergence, the American College Rheumatology's annual meeting, showed that patients with rheumatic diseases whose infliximab treatment was individually assessed and adjusted with a new strategy called therapeutic drug monitoring did not achieve remission at higher rates compared to those who received standard care.
The best protection against new SARS-CoV-2 infections or reinfections may be obtained by a combination of vaccine-elicited and infection-induced antibodies.
Cell reprogramming converts specialised cells such as nerve cells or skin cells towards an embryonic stem cell state. This reversal in the evolutionary development of cells also requires a reversal in the biology of telomeres, the structures that protect the ends of chromosomes; whilst under normal conditions telomeres shorten over time, during cell reprogramming they follow the opposite strategy and increase in length.
› Verified 9 days ago